In the meantime, Maxim Group initiated its Mainz Biomed N.V [MYNZ] rating to a Buy in a research note published on February 14, 2025; the price target was $14. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in late November from “a Buy” to “a Neutral”. Cantor Fitzgerald also remained covering MYNZ and has decreased its forecast on November 21, 2023 with a “Neutral” recommendation from previously “an Overweight” rating. H.C. Wainwright started covering the stock on June 21, 2022. It rated MYNZ as “a Buy”.
Price Performance Review of MYNZ
On Monday, Mainz Biomed N.V [NASDAQ:MYNZ] saw its stock jump 4.82% to $3.70. Over the last five days, the stock has gained 20.52%. Mainz Biomed N.V shares have fallen nearly -14.35% since the year began. Nevertheless, the stocks have fallen -89.71% over the past one year. While a 52-week high of $40.40 was reached on 02/05/25, a 52-week low of $2.65 was recorded on 04/04/25. SMA at 50 days reached $4.29, while 200 days put it at $8.58.
Levels Of Support And Resistance For MYNZ Stock
The 24-hour chart illustrates a support level at 3.37, which if violated will result in even more drops to 3.04. On the upside, there is a resistance level at 4.23. A further resistance level may holdings at 4.76. The Relative Strength Index (RSI) on the 14-day chart is 51.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.20%. Stochastics %K at 69.70% indicates the stock is a holding.
How much short interest is there in Mainz Biomed N.V?
A steep rise in short interest was recorded in Mainz Biomed N.V stocks on 2025-04-15, dropping by 59072.0 shares to a total of 69425.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 0.13 million shares. There was a decline of -85.09%, which implies that there is a negative sentiment for the stock.
